Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Grant or award CEO and President acquired 840,274 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 168,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award 10% owner acquired 2,203,869 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Conversion Former Director and 10% Owner acquired 126,645 shares (conversion)
  8. 4 Conversion Former 10% Owner acquired 126,645 shares (conversion)
  9. 4 Conversion Director acquired 703,588 shares (conversion)
  10. 4 Gift SVP and Chief Medical Officer gave 22,000 shares (gift)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Senior VP of Commercial acquired 4,117 shares (grant or award)
  19. 4 Grant or award VP, Legal and Secretary acquired 2,448 shares (grant or award)
  20. 4 Grant or award Sr VP, CFO, Treasr, Asst Secy acquired 2,448 shares (grant or award)

Page 12 of 20 · 382 filings